Applicator
Latest Pfizer Inc. Patents:
- Dosing Regime For Treatment of Chronic Hand Eczema
- Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one
- Combinations for treatment of NASH/NAFLD and related diseases
- Amorphous Form of (S)-2-(5-((3-Ethoxypyridin-2-YL)Oxy)Pyridin-3-YL)-N-(Tetrahydrofuran-3-YL)Pyrimidine-5-Carboxamide
- Glycoconjugation process
Description
FIG. 1 is a left side elevational view of an applicator showing our new design;
FIG. 2 is a front elevational view thereof;
FIG. 3 is a right side elevational view thereof;
FIG. 4 is a top plan view thereof; and,
FIG. 5 is a bottom plan view thereof.
Referenced Cited
U.S. Patent Documents
D188397 | July 1960 | Hulsh |
D351338 | October 11, 1994 | Koptis |
D401138 | November 17, 1998 | Rosen et al. |
D414688 | October 5, 1999 | Loeb et al. |
1303531 | May 1919 | Albig |
1517914 | December 1924 | MacDonald |
1661607 | March 1928 | Evans |
2021653 | November 1935 | Johnson |
2374065 | April 1945 | Worthington |
4844250 | July 4, 1989 | Holoubek et al. |
5954231 | September 21, 1999 | Durliat et al. |
Patent History
Patent number: D431093
Type: Grant
Filed: Oct 1, 1999
Date of Patent: Sep 19, 2000
Assignee: Pfizer Inc. (New York, NY)
Inventors: Stuart M. Leslie (Larchmont, NY), Charles Curtiss (Long Island City, NY), Chen Jiang (New York, NY)
Primary Examiner: Paula A. Mortimer
Attorneys: Peter C. Richardson, Paul H. Ginsburg, Grover F. Fuller, Jr.
Application Number: 0/111,671
Type: Grant
Filed: Oct 1, 1999
Date of Patent: Sep 19, 2000
Assignee: Pfizer Inc. (New York, NY)
Inventors: Stuart M. Leslie (Larchmont, NY), Charles Curtiss (Long Island City, NY), Chen Jiang (New York, NY)
Primary Examiner: Paula A. Mortimer
Attorneys: Peter C. Richardson, Paul H. Ginsburg, Grover F. Fuller, Jr.
Application Number: 0/111,671
Classifications